Development of an ex-vivo-in-silico framework for predicting maternal and breastfed-infant toxicokinetics
Development of an ex-vivo-in-silico framework for predicting maternal and breastfed-infant toxicokinetics
批准号:
RGPIN-2022-04406
负责人:
Maharaj, Anil
金额:
$1.89万
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Early-life exposure to environmental contaminants from breast-milk is an increasing concern for human risk assessments. The burden of infant exposure to environmental contaminants from breast-milk are largely unknown as levels of chemical agents are not routinely evaluated in this matrix. As a result, our current ability to define tolerable daily intakes, which establish safe exposure thresholds, for environmental contaminants in breastfeeding women remains limited. In most cases, thresholds are defined based on extrapolation from animal studies without consideration for lactation and potential transfer of contaminants to nursing infants. The proposed program of study aims to develop an integrated ex-vivo-in-silico framework to identify environmental contaminants that pose a risk to nursing infants. The program will merge ex-vivo analyses of contaminant partitioning in breast-milk/plasma with in-silico physiologically-based toxicokinetic (PBTK) models to generate rational predictions of internal contaminant exposure nursing infant. PBTK models represent a biologically relevant modelling platform that incorporates information on compound physico-chemistry and human anatomy/physiology to estimate how environmental contaminant exposure translates to internal tissue exposure. The proposed framework will provide risk assessors with a rational approach for establishing exposure thresholds in breastfeeding women for both existing as well emerging environmental contaminants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of an ex-vivo-in-silico framework for predicting maternal and breastfed-infant toxicokinetics
-
批准号:DGECR-2022-00291
-
项目类别:Discovery Launch Supplement
-
资助金额:$0.91万
-
财政年份:2022
-
负责人:Maharaj, Anil
-
依托单位:
Development of a Mechansitic Oral Absorption Model: Focus on Pediatrics
-
批准号:459640-2014
-
项目类别:Alexander Graham Bell Canada Graduate Scholarships - Doctoral
-
资助金额:$2.55万
-
财政年份:2016
-
负责人:Maharaj, Anil
-
依托单位:
Development of a Mechansitic Oral Absorption Model: Focus on Pediatrics
-
批准号:459640-2014
-
项目类别:Alexander Graham Bell Canada Graduate Scholarships - Doctoral
-
资助金额:$2.55万
-
财政年份:2015
-
负责人:Maharaj, Anil
-
依托单位:
Development of a Mechansitic Oral Absorption Model: Focus on Pediatrics
-
批准号:459640-2014
-
项目类别:Alexander Graham Bell Canada Graduate Scholarships - Doctoral
-
资助金额:$2.55万
-
财政年份:2014
-
负责人:Maharaj, Anil
-
依托单位:
Development of Predictive Absorption Models in Pediatrics
-
批准号:420201-2012
-
项目类别:Alexander Graham Bell Canada Graduate Scholarships - Master's
-
资助金额:$1.27万
-
财政年份:2012
-
负责人:Maharaj, Anil
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ColQ基因新突变合并反式EX14-EX15缺失对先天性肌无力5型的致病作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:张晨晖
-
依托单位:
HucMSC-Ex调控巨噬细胞FXR表达抑制铁死亡修复IBD的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:毛飞
-
依托单位:
Sirt1 抑制剂 EX527 在 HBV 相关肝癌脂质代谢重编程中的作用及临床意义
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2024
-
负责人:曹铸敏
-
依托单位:
基于抗菌/消炎/免疫调节研究MDC@Ex-γ3-CeO2@PDA多靶点阻断和协同干预脓毒症急性肺损伤的作用及机制
-
批准号:82372161
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:桂水清
-
依托单位:
EX-4/SDF-1/PLGA复合静电纺丝纤维膜对牙周原位组织再生的协同作用及机制研究
-
批准号:82360193
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:张睿
-
依托单位:
基于IL-23-JAK2/STAT3信号轴探讨鼻敏康合剂调节ex-ILC2/ILC3抑制变应性鼻炎最轻持续性炎症的机制
-
批准号:82305327
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:陈祥静
-
依托单位:
基于ex vivo模型联合多组学手段绘制胃癌曲妥珠单抗继发耐药机制并探索克服耐药策略
-
批准号:82072728
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:高静
-
依托单位:
以EX1和EX2为靶标的stargazin和AMPA受体相互作用研究
-
批准号:81872848
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:张炜
-
依托单位:
基于T2ex原理的新型镧系金属造影剂的设计及应用
-
批准号:21801235
-
项目类别:青年科学基金项目
-
资助金额:27.5万元
-
批准年份:2018
-
负责人:张磊
-
依托单位:
磷酸化和可变剪切修饰影响Bnip3调控线粒体自噬和细胞凋亡的结构及功能研究
-
批准号:31670742
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2016
-
负责人:张星亮
-
依托单位: